Gelesis is developing a novel hydrogel platform technology to treat overweight and obesity and chronic diseases related to the GI pathway. Gelesis’ proprietary approach is designed to act mechanically in the GI pathway to potentially alter the course of certain chronic diseases. In April 2019, Gelesis received FDA clearance for its lead product candidate, Plenity™, as an aid for weight management in overweight and obese adults with a Body Mass Index (BMI) of 25-40 kg/m2, when used in conjunction with diet and exercise. Plenity is currently available in limited supply in the U.S. Additionally, Gelesis is developing its second investigational candidate, Gelesis200, a hydrogel optimized for weight loss and glycemic control in patients with type 2 diabetes and prediabetes. Novel hydrogel mechanotherapeutics based on the Gelesis platform technology are also being advanced in other GI inflammatory conditions, such as non-alcoholic steatohepatitis (NASH) and Chronic Idiopathic Constipation (CIC).
Gelesis was also named one of Fast Company’s Most Innovative Companies for 2020.
The Gelesis executive and advisory team includes some of the world’s leading experts in obesity, materials science, chronic disease research, and commercialization. Gelesis was co-founded by PureTech Health (LSE: PRTC). For more information, visit gelesis.com or connect with us on Twitter @GelesisInc.
The Medical Affairs Manager; Medical Communications/ Scientific Communications will be a key member of the Gelesis Medical Team. The candidate will have strong knowledge of the Medical Affairs function, particularly medical information, medical communication, promotional review committee, congress and publication planning. Responsible for analyzing, tracking, and continuous improvement of medical affairs processes, systems, procedures, and SOPs. Works with doctors, scientists, and other subject matter experts, to create documents that effectively and clearly describe research results, product use, and other medical information. Ensures the documents comply with regulatory, journal, or other guidelines in terms of content, format and structure. Responds to inquiries from HCP’s, including unsolicited requests for off-label information.
Gelesis currently has a product with an indication for weight management in overweight and obese patients, in addition to pursing opportunities within GI, and NASH/NAFLD. Experts in product development in these therapeutic areas, as well as candidates with broad therapeutic area experience and/or complementary and relevant scientific expertise are of interest. The role will report into the VP of Medical Affairs.
This position will be based in Boston, MA. The position is expected to work remotely during the pandemic. However, the candidate may be expected to report to the office in the future as determined by management. Up to 10% travel.
Gelesis is an equal opportunity employer. All aspects of employment including the decision to hire, promote, discipline, or discharge, will be based on merit, competence, performance, and business needs. We do not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, veteran status, a person’s size or weight, or any other status protected under federal, state, or local law.
Please send resumes and expression of interest to: firstname.lastname@example.org